MUCOSAL MELANOMA
Clinical trials for MUCOSAL MELANOMA explained in plain language.
Never miss a new study
Get alerted when new MUCOSAL MELANOMA trials appear
Sign up with your email to follow new studies for MUCOSAL MELANOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Immune cell therapy shows promise for Hard-to-Treat melanoma
Disease control CompletedThis early-phase study tested a new treatment called TBio-4101 for people with advanced melanoma that did not respond to standard therapies. The treatment uses a patient's own immune cells (TILs) that are grown in a lab and given back after chemotherapy and a drug called IL-2. Th…
Matched conditions: MUCOSAL MELANOMA
Phase: PHASE1 • Sponsor: H. Lee Moffitt Cancer Center and Research Institute • Aim: Disease control
Last updated May 15, 2026 11:53 UTC
-
New combo therapy shows promise for brain metastases
Disease control CompletedThis early-stage study tested a combination of an immunotherapy drug (pembrolizumab) and precise radiation (stereotactic radiosurgery) in 25 people with melanoma or lung cancer that had spread to the brain. The main goal was to check for serious side effects. The approach aims to…
Matched conditions: MUCOSAL MELANOMA
Phase: PHASE1 • Sponsor: Emory University • Aim: Disease control
Last updated May 13, 2026 15:58 UTC
-
PET scans may help predict survival in rare melanoma
Knowledge-focused CompletedThis study looked at 68 people with mucosal melanoma, a rare type of cancer. Researchers used FDG PET/CT scans to see if imaging details could predict how long patients live or when their disease might get worse. The goal is to help doctors make better treatment choices based on …
Matched conditions: MUCOSAL MELANOMA
Sponsor: Union Hospital, Tongji Medical College, Huazhong University of Science and Technology • Aim: Knowledge-focused
Last updated May 17, 2026 02:00 UTC